Pancreatic tumor pathogenesis
The study, published on Nature by San Raffaele researchers, identifies a new possible therapeutic target that could slow the process of a pancreatic tumour
MOREA molecular "silencer" makes leukemia cells invisible
The discovery paves the way for new treatments of AML relapses post transplantation
MOREPromising preclinical results for TCR T-cells in AML
The first clinical trial in AML patients, sponsored by Intellia Therapeutics, already began in UK and USA
MOREHighlights
Luca Guidotti receives Career Award for his research on hepatitis B
HBV International Meeting in Kobe, Japan, awarded to
In vivo gene therapy equips the immune system against liver metastases
A San Raffaele study demonstrates, in experimental models, the effectiveness of a new gene...
PHIRE project
San Raffaele Hospital is coordinator of the first European EIC Transition project that aims...
Research Highlights
Great research leads to great results. Our pioneering science in numbers.
Research integrity
Upholding high standards of quality, trustworthiness and reproducibility
Industry collaborations
Join the excellence. Explore our integrated biomedical innovation pipeline.
Science outreach
Bridging the gap between science and society, for the benefit of both.